Fluoroquinolone and macrolide resistance-associated mutations in Mycoplasma genitalium

scientific article published on 08 May 2013

Fluoroquinolone and macrolide resistance-associated mutations in Mycoplasma genitalium is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1128/JCM.00495-13
P932PMC publication ID3697725
P698PubMed publication ID23658265

P50authorLyn GilbertQ90698221
P2093author name stringKaitlin A Tagg
Deborah L Couldwell
Jennifer A Donald
Neisha J Jeoffreys
P2860cites workAntibiotic treatment of symptomatic Mycoplasma genitalium infection in Scandinavia: a controlled clinical trialQ46954398
Selection of Mycoplasma genitalium strains harbouring macrolide resistance-associated 23S rRNA mutations by treatment with a single 1 g dose of azithromycin.Q54359754
A NEWLY DISCOVERED MYCOPLASMA IN THE HUMAN UROGENITAL TRACTQ56057554
Mycoplasma genitalium: an emerging cause of sexually transmitted disease in womenQ21131426
The Minimal Gene Complement of Mycoplasma genitaliumQ22065573
Molecular biology and pathogenicity of mycoplasmasQ24548575
Induced macrolide resistance in Mycoplasma genitalium isolates from patients with recurrent nongonococcal urethritisQ24605678
Association between Mycoplasma genitalium and acute endometritisQ28206155
Persistence of Mycoplasma genitalium following azithromycin therapyQ33382111
Mycoplasma genitalium as a contributor to the multiple etiologies of cervicitis in women attending sexually transmitted disease clinicsQ34076727
Macrolide resistance conferred by base substitutions in 23S rRNA.Q34106180
Sexually transmitted diseases treatment guidelines, 2010.Q34155140
Mycoplasma genitalium PCR: does freezing of specimens affect sensitivity?Q34190405
Transmission and selection of macrolide resistant Mycoplasma genitalium infections detected by rapid high resolution melt analysisQ34245136
Etiologies of nongonococcal urethritis: bacteria, viruses, and the association with orogenital exposureQ34481060
Mycoplasma genitalium: another important pathogen of nongonococcal urethritisQ34520839
Re-evaluating the treatment of nongonococcal urethritis: emphasizing emerging pathogens--a randomized clinical trialQ35019879
Mycoplasma genitalium: from Chrysalis to multicolored butterflyQ35090137
Detection of mutations in parC in quinolone-resistant clinical isolates of Escherichia coli.Q35122643
Associations between Mycoplasma genitalium, Chlamydia trachomatis, and pelvic inflammatory diseaseQ35530456
Azithromycin failure in Mycoplasma genitalium urethritisQ35792616
DNA gyrase and topoisomerase IV mutations in clinical isolates of Ureaplasma spp. and Mycoplasma hominis resistant to fluoroquinolonesQ36047665
Mycoplasma genitalium in cervicitis and pelvic inflammatory disease among women at a gynecologic outpatient serviceQ37849026
Mycoplasma genitalium is associated with cervicitis and HIV infection in an urban Australian STI clinic populationQ37851970
Ureaplasma urealyticum is significantly associated with non-gonococcal urethritis in heterosexual Sydney men.Q37853014
The association between Mycoplasma genitalium and pelvic inflammatory disease after termination of pregnancyQ37853910
Activity of moxifloxacin against the urogenital mycoplasmas Ureaplasma spp., Mycoplasma hominis and Mycoplasma genitalium and Chlamydia trachomatis.Q37856727
Role of Mycoplasma genitalium and Ureaplasma urealyticum in acute and chronic nongonococcal urethritisQ37874585
Association of Mycoplasma genitalium with nongonococcal urethritis in heterosexual men.Q37875161
Mycoplasma genitalium in the cervices of Japanese womenQ37882938
Quinolone resistance-determining region in the DNA gyrase gyrA gene of Escherichia coliQ39816339
In vitro development of resistance to six and four fluoroquinolones in Mycoplasma pneumoniae and Mycoplasma hominis, respectivelyQ41092975
Antimicrobial susceptibilities of Mycoplasma genitalium strains examined by broth dilution and quantitative PCR.Q42111508
Emergence of clinical strains of Mycoplasma genitalium harbouring alterations in ParC associated with fluoroquinolone resistanceQ43004634
Macrolide resistance-associated 23S rRNA mutation in Mycoplasma genitalium, JapanQ43180518
Comparison of full gyrA, gyrB, parC and parE gene sequences between all Ureaplasma parvum and Ureaplasma urealyticum serovars to separate true fluoroquinolone antibiotic resistance mutations from non-resistance polymorphism.Q45835656
Azithromycin treatment failure in Mycoplasma genitalium-positive patients with nongonococcal urethritis is associated with induced macrolide resistanceQ46260038
Azithromycin and moxifloxacin for microbiological cure of Mycoplasma genitalium infection: an open studyQ46340504
P433issue7
P407language of work or nameEnglishQ1860
P921main subjectMycoplasma genitaliumQ1930909
P304page(s)2245-2249
P577publication date2013-05-08
P1433published inJournal of Clinical MicrobiologyQ4041880
P1476titleFluoroquinolone and macrolide resistance-associated mutations in Mycoplasma genitalium
P478volume51

Reverse relations

cites work (P2860)
Q378364942016 European guideline on the management of non-gonococcal urethritis
Q36933110A 5' Nuclease Genotyping Assay for Identification of Macrolide-Resistant Mycoplasma genitalium in Clinical Specimens.
Q37280597A Novel SimpleProbe PCR Assay for Detection of Mutations in the 23S rRNA Gene Associated with Macrolide Resistance in Mycoplasma genitalium in Clinical Samples.
Q37572093A cross-sectional study of Mycoplasma genitalium infection and correlates in women undergoing population-based screening or clinic-based testing for Chlamydia infection in London
Q28554374Antimicrobial Susceptibility Patterns of Recent Cuban Mycoplasma genitalium Isolates Determined by a Modified Cell-Culture-Based Method
Q38772340Antimicrobial-resistant sexually transmitted infections: gonorrhoea and Mycoplasma genitalium
Q37382490Bacterial Load in Daily Urine Samples of Patients Infected with Mycoplasma genitalium, Mutation Analysis, and Response to Treatment
Q37844311Cervicitis of unknown etiology
Q30235030Chlamydia trachomatis Genital Infections
Q38609853Developing a Public Health Response to Mycoplasma genitalium
Q37844334Diagnosis and antimicrobial treatment of Mycoplasma genitalium infection: sobering thoughts
Q37713726Direct detection of macrolide resistance in Mycoplasma genitalium isolates from clinical specimens from France by use of real-time PCR and melting curve analysis
Q35673469Drug resistance-associated mutations in Mycoplasma genitalium in female sex workers, Japan
Q38646438Efficacy of Antimicrobial Therapy for Mycoplasma genitalium Infections
Q42319628Evaluation of a Commercial Multiplex Quantitative PCR (qPCR) Assay for Simultaneous Detection of Mycoplasma genitalium and Macrolide Resistance-Associated Mutations in Clinical Specimens
Q42339724Fluoroquinolone-Resistant Mycoplasma genitalium, Southwestern France
Q40099689French Prospective Clinical Evaluation of the Aptima Mycoplasma genitalium CE-IVD Assay and Macrolide Resistance Detection Using Three Distinct Assays.
Q40917407High levels of macrolide resistance-associated mutations in Mycoplasma genitalium warrant antibiotic susceptibility-guided treatment.
Q37579937High prevalence of antibiotic-resistant Mycoplasma genitalium in nongonococcal urethritis: the need for routine testing and the inadequacy of current treatment options.
Q40346692High prevalence of the A2058T macrolide resistance-associated mutation in Mycoplasma genitalium strains from the Netherlands
Q40103287In Vitro Activities of Gepotidacin (GSK2140944) and Other Antimicrobial Agents Against Human Mycoplasmas and Ureaplasmas
Q33597030Increasing Macrolide and Fluoroquinolone Resistance in Mycoplasma genitalium
Q37839814Large two-centre study into the prevalence of Mycoplasma genitalium and Trichomonas vaginalis in the Netherlands
Q57035503Long duration of asymptomatic Mycoplasma genitalium infection after syndromic treatment for nongonococcal urethritis
Q48537471Macrolide and fluoroquinolone resistance in Mycoplasma genitalium in two Swedish counties, 2011-2015.
Q64239107Macrolide and fluoroquinolone resistance-associated mutations in Mycoplasma genitalium in Johannesburg, South Africa, 2007-2014
Q41583528Macrolide resistance and azithromycin failure in a Mycoplasma genitalium-infected cohort and response of azithromycin failures to alternative antibiotic regimens
Q64999477Macrolide-Resistant Mycoplasma genitalium in Southeastern Region of the Netherlands, 2014-2017.
Q59799969Macrolide-resistant Mycoplasma genitalium infections in Cuban patients: an underestimated health problem
Q26796722Management of Mycoplasma genitalium infections - can we hit a moving target?
Q24658574Mass drug administration of azithromycin for trachoma reduces the prevalence of genital Chlamydia trachomatis infection in the Solomon Islands
Q92755899Multicenter Clinical Evaluation of a Novel Multiplex Real-Time PCR (qPCR) Assay for Detection of Fluoroquinolone Resistance in Mycoplasma genitalium
Q53812158Multidrug-Resistant Mycoplasma genitalium Is Increasing.
Q40271087Multidrug-resistant Mycoplasma genitalium infections in Europe
Q55234408Mutations in ParC and GyrA of moxifloxacin-resistant and susceptible Mycoplasma genitalium strains.
Q92798143Mycoplasma genitalium Antimicrobial Resistance in Community and Sexual Health Clinic Patients, Auckland, New Zealand
Q58699936Mycoplasma genitalium in the Far North Queensland backpacker population: An observational study of prevalence and azithromycin resistance
Q27021073Mycoplasma genitalium infection: current treatment options, therapeutic failure, and resistance-associated mutations
Q42355223Mycoplasma genitalium infections: current treatment options and resistance issues
Q40063952Mycoplasma genitalium macrolide and fluoroquinolone resistance detection and clinical implications in a selected cohort in New Zealand
Q35008363Mycoplasma genitalium testing pattern and macrolide resistance: a Danish nationwide retrospective survey
Q40071934Mycoplasma genitalium: Accurate Diagnosis Is Necessary for Adequate Treatment
Q26748959Mycoplasma genitalium: An Emerging Sexually Transmitted Infection
Q26747053Mycoplasma genitalium: An Overlooked Sexually Transmitted Pathogen in Women?
Q28910390N-Terminal Polypeptide of Annexin A2 Decreases Infection of Mycoplasma hyorhinis to Gastric Cancer Cells
Q38609857New Horizons in Mycoplasma genitalium Treatment
Q37833830Prevalence and antibiotic resistance of Mycoplasma genitalium among STI clinic attendees in Western Canada: a cross-sectional analysis
Q33562762Prevalence of macrolide and fluoroquinolone resistance-mediating mutations in Mycoplasma genitalium in five cities in Russia and Estonia
Q97075329Prevalence of mutations associated with resistance to macrolides and fluoroquinolones in Mycoplasma genitalium: a systematic review and meta-analysis
Q28647996Prevalence of sexually transmitted infections in female clinic attendees in Honiara, Solomon Islands
Q42212384Remarkable increase in fluoroquinolone-resistant Mycoplasma genitalium in Japan.
Q59296685Reply to Deguchi et al
Q34479272Sexually transmitted diseases treatment guidelines, 2015.
Q38560388The Efficacy of Azithromycin for the Treatment of Genital Mycoplasma genitalium: A Systematic Review and Meta-analysis
Q35052845Treatment efficacy, treatment failures and selection of macrolide resistance in patients with high load of Mycoplasma genitalium during treatment of male urethritis with josamycin
Q64098896Turning the Tide against Antibiotic Resistance by Evaluating Novel, Halogenated Phenazine, Quinoline, and NH125 Compounds against Species Clinical Isolates and Type Strains
Q37839072Ureaplasma parvum and Mycoplasma genitalium are found to be significantly associated with microscopy-confirmed urethritis in a routine genitourinary medicine setting

Search more.